Yoshihiro Hatta

5PUBLICATIONS
15CO-AUTHORS
HaematologyPharmaceutical delivery technologiesPredictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 05, 2024
Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission.

Satoshi Nishiwaki, Isamu Sugiura, Shin Fujisawa

|Jan 02, 2024
Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study.

Masataka Kuwana, Tomoki Ito, Shugo Kowata

|Oct 10, 2020
The EUTOS long-term survival score predicts disease-specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice-based cohort.

Eriko Sato, Noriyoshi Iriyama, Michihide Tokuhira

|Jan 31, 2019
A novel fusion gene involving PDGFRB and GCC2 in a chronic eosinophilic leukemia patient harboring t(2;5)(q37;q31).

Noriyoshi Iriyama, Hiromichi Takahashi, Hiromu Naruse

|Apr 26, 2018
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL.

Yoshihiro Hatta, Shuichi Mizuta, Keitaro Matsuo

Pageof 1

Frequent Collaborators

2 joint publications

Noriyoshi Iriyama

1 joint publications

Eriko Sato

1 joint publications

Tomoiku Takaku

1 joint publications

Maho Ishikawa